2-methyl-2-hexyl methyl ether | 89045-00-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-methyl-2-hexyl methyl ether
• 英文别名: 2-methoxy-2-methylhexane；tert-heptyl methyl ether
• CAS: 89045-00-1
• 化学式: C₈H₁₈O
• 分子量: 130.23
• InChiKey: JFWIOFGVMQJBNT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  丙烷 生成 2-methyl-2-hexyl methyl ether
  参考文献：
  名称：

  DEBRAS, GUY L. G.;CAHEN, RAYMOND M.;DE, CLIPPELEIR GEORGES E. M. J.

  摘要：

  DOI：

文献信息

• Methylation of Alcohols, Phenols, and Carboxylic Acids, and Selective Monomethylation of Diols and Dicarboxylic Acids with Dimethyl Sulfate by Use of Alumina
  作者：Haruo Ogawa、Youko Ichimura、Teiji Chihara、Shousuke Teratani、Kazuo Taya

  DOI：10.1246/bcsj.59.2481

  日期：1986.8

  Alcohols in cyclohexane give their methyl ethers in high yields by the use of a combination of dimethyl sulfate and alumina. Some diols and dicarboxylic acids adsorbed on alumina react with dimethyl sulfate and produce the corresponding monomethyl ethers and esters in high selectivities.

  通过使用硫酸二甲酯和氧化铝的组合，环己烷中的醇以高产率得到它们的甲基醚。一些吸附在氧化铝上的二醇和二元羧酸与硫酸二甲酯反应并以高选择性生成相应的单甲醚和酯。
• [EN] QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS<br/>[FR] COMPOSÉS CONTENANT DE LA QUINOXALINE EN TANT QU'INHIBITEURS DU VIRUS DE L'HÉPATITE C
  申请人：ENANTA PHARM INC

  公开号：WO2009064975A1

  公开（公告）日：2009-05-22

  The present invention discloses compounds of formula I and II or pharmaceutically acceptable salts, esters, or prodrugs thereof which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

  本发明公开了抑制丝氨酸蛋白酶活性的I和II公式化合物，或其药物可接受的盐、酯或前药，尤其是抑制丙型肝炎病毒（HCV）NS3-NS4A蛋白酶的活性。因此，本发明的化合物干扰丙型肝炎病毒的生命周期，并且也用作抗病毒剂。本发明进一步涉及包含前述化合物的药物组合物，用于给患有HCV感染的主体进行管理。本发明还涉及通过管理包含本发明化合物的药物组合物来治疗主体中的HCV感染的方法。
• Acid-induced 13C nuclear magnetic resonance chemical shift changes of ether and ester carbon atoms
  作者：Mikael Begtrup

  DOI：10.1039/p29830001609

  日期：——

  13 C N.m.r. chemical shifts of ethers dissolved in tetrachloromethane are displaced on addition of trifluoroacetic acid. The displacements result from independent interactions of the acid with the substrate oxygen atoms and alkyl residues. The structure-dependent and stereoselective shift changes are useful for signal assignments, structure determination, conformational analysis, assessment of the

  溶解在四氯甲烷中的醚的13 C Nmr化学位移可通过添加三氟乙酸来置换。位移是由酸与底物氧原子和烷基残基的独立相互作用导致的。依赖于结构的和立体选择性的移位变化可用于信号分配，结构确定，构象分析，评估酯的快速互变构象异构体的分布以及估算醚的相对碱性。
• Nucleophilic Alkoxylations of Unactivated Alkyl Olefins and α‐Methyl Styrene by Photoredox Catalysis
  作者：Fabienne Seyfert、Mathis Mitha、Hans‐Achim Wagenknecht

  DOI：10.1002/ejoc.202001533

  日期：2021.2.5

  The photoredox catalytic addition of alcohols to non‐activated terminal alkyl olefins is obtained by the use of N,N‐diisobutylamino‐phenylphenothiazine. Its excited state redox potential is sufficiently high to promote the photoreduction.

  通过使用N，N-二异丁基氨基-苯基吩噻嗪可以将醇类光氧化还原催化加成到未活化的末端烷基烯烃上。其激发态氧化还原电势足够高以促进光还原。
• Substituted Azaspiro(4.5)Decane Derivatives
  申请人：Gruenenthal GmbH

  公开号：US20160016903A1

  公开（公告）日：2016-01-21

  The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the μ opioid receptor and the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

  这项发明涉及对取代的螺环烷环己烷衍生物，其具有对μ阿片受体和ORL1受体的亲和力，以及其制备方法、含有这些化合物的药物和利用这些化合物制备药物的用途。